SCHEMBL5340705

SCHEMBL5340705

CCOC(=O)C1=C(C)NC(=O)NC1c1ccc(Cl)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.75
CA12 O43570 1/20 0.72
CA1 P00915 1/20 0.72
CA2 P00918 1/20 0.72
CA7 P43166 1/20 0.72
CA9 Q16790 1/20 0.72
GAA P10253 2/20 0.71
MAPK1 P28482 2/20 0.70
L3MBTL1 Q9Y468 1/20 0.69
ADORA2B P29275 3/20 0.67
TSHR P16473 2/20 0.67
POLB P06746 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
ABCC1 P33527 1/20 0.67
ALDH1A1 P00352 1/20 0.67
KIF11 P52732 1/20 0.66
PKM P14618 1/20 0.64
HTT P42858 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19752680 0.90 HSD17B10 (0.77) HSD17B10CA12CA1CA2CA7
SCHEMBL1227524 0.90 HSD17B10 (0.77) HSD17B10CA12CA1CA2CA7
SCHEMBL10112951 0.89 HSD17B10 (0.76) HSD17B10CA12CA1CA2CA7
SCHEMBL28484545 0.88 HSD17B10 (0.70) HSD17B10CA12CA1CA2CA7
SCHEMBL24624782 0.88 MAPK1 (0.68) HSD17B10CA12CA1CA2CA7
SCHEMBL19752649 0.88 MAPT (0.78) HSD17B10CA12CA1CA2CA7
SCHEMBL19752622 0.88 MAPT (0.78) HSD17B10CA12CA1CA2CA7
SCHEMBL5340383 0.88 MAPT (0.78) HSD17B10CA12CA1CA2CA7
SCHEMBL28490632 0.88 HSD17B10 (0.73) HSD17B10CA12CA1CA2CA7
SCHEMBL18025267 0.88 KIF11 (0.75) HSD17B10CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215108-A1 DUAL G9A/GSK-3ß INHIBITORS UNIVERSITAT DE BARCELONA (ES) 2025-10-16 WO claimed
WO-2025215108-A1 DUAL G9A/GSK-3ß INHIBITORS UNIVERSITAT DE BARCELONA (ES) 2025-10-16 WO disclosed
CN-112812066-B Synthesis method of dihydropyrimidinone compound 宜春学院 2023-04-25 CN disclosed
CN-110437100-B Preparation method and application of novel ionic salicylaldehyde Schiff base zirconium complex 山西医科大学 2022-03-11 CN disclosed
CN-106632071-B Method for preparing 3, 4-dihydropyrimidine-2-one derivative by promoting high-efficiency catalysis of titanocene dichloride with ethanol 陕西师范大学 2021-07-09 CN disclosed
CN-112812066-A Synthesis method of dihydropyrimidinone compounds 宜春学院 2021-05-18 CN disclosed
WO-2017134188-A1 NOVEL DIHYDROPYRIDINONE AND DIHYDROPYRIMIDINONE COMPOUNDS AND THEIR USE UNIVERSITE DE LILLE 2 DROIT ET SANTE (FR) 2017-08-10 WO disclosed
WO-2017134188-A1 NOVEL DIHYDROPYRIDINONE AND DIHYDROPYRIMIDINONE COMPOUNDS AND THEIR USE UNIVERSITE DE LILLE 2 DROIT ET SANTE (FR) 2017-08-10 WO disclosed
WO-2007101213-A2 NOVEL 2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINES, BICYCLIC PYRIMIDINE DIONES AND IMIDAZOLIDINE-2,4-DIONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2007-09-07 WO disclosed
WO-2007101213-A2 NOVEL 2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINES, BICYCLIC PYRIMIDINE DIONES AND IMIDAZOLIDINE-2,4-DIONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2007-09-07 WO disclosed